EVALUATION OF PATIENTS WITH THROMBOCYTOPENIA: A CROSS-SECTIONAL STUDY

Main Article Content

Dr. Smithkumar Narendrakumar Modi
Dr Maulik Pradipbhai Panchal
Dr. Chintan Pravinchandra Patil
Dr. Karmarajsinh Dilipsinh Vaghela
Dr Vidhi Atul Kumar Modi

Keywords

Thrombocytopenia, platelet transfusion, bleeding, dengue, malaria, disease management

Abstract

Objective: This study aimed to evaluate the clinical characteristics, etiologies, laboratory findings, and management of patients diagnosed with thrombocytopenia in a tertiary care setting.


Methods: A cross-sectional, hospital-based study was conducted in the Department of Medicine at a tertiary care institute over two years. The study included 80 patients aged 14 years and above with platelet counts below 100,000 per cubic millimetre. Patients with thrombocytopenia secondary to cirrhosis, malignancy, chemotherapy, or congenital disorders were excluded. Clinical history, physical examination, and laboratory investigations were performed. Treatment included platelet transfusions and disease-specific therapies based on clinical presentations. Data were analyzed using descriptive statistics.


Results: Most patients were aged 21-30 (27.5%), and 57.5% were male. Hemorrhagic manifestations were observed in 60% of patients, while fever and joint pain were present in 50% and 37%, respectively. Splenomegaly was noted in 26.25% of patients, hepatomegaly in 11.25%, and hepatosplenomegaly in 10%. Dengue (33.75%) and malaria (26.25%) were the leading causes of thrombocytopenia, followed by megaloblastic anaemia (15%) and cirrhosis (13.75%). Bleeding manifestations were present in 22.5% of patients, with mucosal bleeding being the most common (61.11%). Platelet transfusions were given to 21 patients: 7 with platelet counts below 10,000/mm³ and 14 with counts above 10,000/mm³. Disease-specific treatment was required for 73.75% of patients, with most having platelet counts above 10,000/mm³.


Conclusion: Infectious causes, particularly dengue and malaria, were the most common etiologies of thrombocytopenia. Bleeding was more prevalent in patients with lower platelet counts. Early cause identification and appropriate management, including transfusions and disease-specific treatments, were crucial in improving outcomes.

Abstract 52 | PDF Downloads 9

References

1. Paramjit E, Rao R, Sudhamani S, Roplekar P, Shaffi Z, Roy S. Spectrum of thrombocytopenia: A clinico pathological study with review of the literature. Muller J Med Sci Res. 2016;7(2):121.
2. Ishikawa K, Uchida T. [Cyclic thrombocytopenia diagnosed by periodic platelet count measurements]. Rinsho Ketsueki. 2023;64(1):66-68.
3. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-65.
4. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86(2):419-31.
5. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37(1):5-9.
6. Lichtman MA. Hematological complications of human immunodeficiency virus (HIV) infection. Best Pract Res Clin Haematol. 2000;13(2):369-90.
7. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7(6):911-8.
8. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341(8):586-92.
9. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654-66.
10. Yan L, Xu S, Yang X, Luo Z, Huang C. Decision-making error in platelet transfusion caused by EDTA-dependent pseudothrombocytopenia: a case report and literature review. Clin Lab. 2024;70(1):1-4. doi:10.7754/clin.lab.2023.230703.
11. Markewitz R, Sharifzadeh S, Junker R, Wandinger KP. EDTA-associated pseudothrombocytopenia: definition and real-world occurrence. Lab Med. 2023;47(2):123-30.
12. Sokolova NA, Savina MI, Shokhina OS. EDTA-dependent pseudothrombocytopenia in a child: clinical case report. J Clin Med. 2021;13(1):51-54.
13. Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. Guidelines for the use of platelet transfusions. Br J Haematol. 2017;176(3):365-94.
14. Neunert C. Update on immune thrombocytopenia: mechanisms and management. Hematology Am Soc Hematol Educ Program. 2021;2021(1):384-91.
15. Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85(6):612-22.
19.
16. Shah HR, Vaghani BD, Gohel P, Virani BK. Clinical profile review of patients with thrombocytopenia: A study of 100 cases at a tertiary care centre. Int J Curr Res Rev. 2015; 7(6):33-37.
17. Mural R, Manohar MR. Study of clinical profile of thrombocytopenia. Int J Contemp Med Res. 2017;4(9):1886-1888.
18. Khatib Y, Jain V, Patel R. One year study of thrombocytopenia in a peripheral hospital of Mumbai. IOSR J Pharm. 2016;6(4):26-30.
19. Lakshmikumar MT, Bettegowda S, Joseph S. A clinical study of febrile thrombocytopenia with special reference to complications and seasonal variation. Int J Res Rev. 2019;6(7):468-475.
20. Gondhali MP, Vethekar M, Bhangale D, Choudhary K, Chaudhary M, Patrike G, Kundgir A. Clinical assessment of fever with thrombocytopenia - A prospective study. Int J Med Res Health Sci. 2016;5(1):258-277.
21. Nair PS Jain A, Khanduri U, Kumar V. A study of fever associated with thrombocytopenia , JAPI, 2003 Dec;51:1173.
22. Vimal M, Parveen S. Clinico pathological profile of spectrum of thrombocytopenic cases – a cross sectional study. Trop J Pathol Microbiol. 2016;2(3):146-151.
23. Ali N, Anwar M, Majeed I, Tariq WU. Chicken pox associated thrombocytopenia in adults. J Coll Physicians Surg Pak. 2006 Apr 1;16(4):270-72.
24. Mittra P, Pandey MK. Clinicopathological profile of thrombocytopenia in Sitapur and Shahjahanpur districts of Uttar Pradesh. Int J Contemp Med Res. 2019;6(1):A25-A27.
25. Bhalara SK, Shah S, Goswami H, Gonsai RN. Clinical and etiological profile of thrombocytopenia in adults: A tertiary-care hospital-based cross-sectional study. Int J Med Sci Public Health. 2015;4:7-10.